The deal would value Soho House at around $1.8 billion, with investors paying around $9 a share for its public stock ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Among Nvidia, Microsoft, Apple, Alphabet, Amazon, Meta Platforms, and Tesla are two sensational businesses that can become ...

IPO despite weak fundamentals, limited core revenue, and unsustainable profits driven by crypto gains. Find out why BLSH ...

Copenhagen-listed shares in pharmaceuticals giant Novo Nordisk (NOVO-B.CO) rose nearly 4% on Monday morning, after the ...